Hiltner, Theresa
Kohlruss, Meike
Herz, Anna-Lina
Lorenzen, Sylvie
Novotny, Alexander
Hapfelmeier, Alexander
Jesinghaus, Moritz
Slotta-Huspenina, Julia
Sisic, Leila
Gaida, Matthias M.
Weichert, Wilko
Ott, Katja
Keller, Gisela http://orcid.org/0000-0003-2886-0371
Funding for this research was provided by:
Deutsche Krebshilfe (70112177, 70112380, 70112177, 70112177)
Wilhelm Sander-Stiftung (2019.156.1)
Technische Universität München
Article History
Received: 13 February 2023
Accepted: 10 March 2023
First Online: 31 March 2023
Declarations
:
: WW has attended advisory boards and served as a speaker for Roche, MSD, BMS, AstraZeneca, Pfizer, Merck, Lilly, Boehringer, Novartis, Takeda, Bayer, Amgen, Astellas, Eisai, Johnson & Johnson, Janssen, Illumina, Siemens, Agilent, ADC, GSK, and Molecular Health. WW received research funding from Roche, MSD, BMS, and AstraZeneca.
: WW has attended advisory boards and served as a speaker for Roche, MSD, BMS, AstraZeneca, Pfizer, Merck, Lilly, Boehringer, Novartis, Takeda, Bayer, Amgen, Astellas, Eisai, Johnson & Johnson, Janssen, Illumina, Siemens, Agilent, ADC, GSK, and Molecular Health. WW received research funding from Roche, MSD, BMS, and AstraZeneca.